Loading
Perseus Proteomics Inc.: what insiders have been doing
Insider filings for Perseus Proteomics Inc. are scarce in the EDINET (Japan FSA) feed, the latest one published on 22 July 2024. This page will fill in as new trades are disclosed. Every figure here comes from the filings published by EDINET (Japan FSA) and describes the past, not future prices; it is not investment advice.
Insider Decl.
3
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Fundamental score
Ranked 19,374 of 23,476 companies
28.8
score / 100
Value8
Quality50
FCF yld-27%
Earn yld-30%
EV/EBITDA·
ROE-54%
Gross mgn86%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
JP¥143
Analyst consensus
Income statement
RevenueJP¥135.5M
Gross profitJP¥116.2M86% margin
EBITDA-JP¥744.6M-549% margin
Net income-JP¥718.1M-529.9% margin
Valuation
P/Book2.0x
Beta0.32
Balance sheet & cash
Market capJP¥2.4B
Free Cash Flow-JP¥663.3M
Profitability & ownership
ROE-54.2%
ROA-27.1%
% insiders4.0%
% institutions9.7%
Last declaration on 22 July 2024
Declarations3 total
ShareXTKSEDINET:S100U2WI
ShareXTKSEDINET:S100TZLU
ShareXTKSEDINET:S100TOUD
3 of 3 declarations
About Perseus Proteomics Inc.
Perseus Proteomics Inc. is a Japanese company specializing in proteomics. It is listed on the XTKS market.